Abstract

http://ssrn.com/abstract=1461884
 
 

References (32)



 
 

Citations (28)



 


 



Assessing TARP


Dinara Bayazitova


University of North Carolina at Chapel Hill

Anil Shivdasani


University of North Carolina Kenan-Flagler Business School

August 19, 2011


Abstract:     
We study the government equity infusions and the incentives of banks to participate in the Capital Purchase Program (CPP) of the Troubled Asset Relief Program (TARP). We show that strong banks opted out of participating in CPP and that equity infusions were provided to banks that posed systemic risk, faced high financial distress costs, but had strong asset quality. Concerns over executive compensation restrictions accompanying TARP led banks to reject CPP infusions and exit the program. CPP infusions did not have meaningful certification effects but the subsequent stress tests conducted for the major banks had significant certification effects. We show that CPP equity infusions altered investor expectations regarding future regulatory interventions in the banking sector.

Number of Pages in PDF File: 41

Keywords: Troubled Asset Relief Program, TARP, CPP, Bailout, Banking Crisis

JEL Classification: G18, G21, G28

working papers series





Download This Paper

Date posted: August 27, 2009 ; Last revised: September 22, 2012

Suggested Citation

Bayazitova, Dinara and Shivdasani, Anil, Assessing TARP (August 19, 2011). Available at SSRN: http://ssrn.com/abstract=1461884 or http://dx.doi.org/10.2139/ssrn.1461884

Contact Information

Dinara Bayazitova
University of North Carolina at Chapel Hill ( email )
Chapel Hill, NC 27599
United States
Anil Shivdasani (Contact Author)
University of North Carolina Kenan-Flagler Business School ( email )
Kenan-Flagler Business School
Chapel Hill, NC 27599-3490
United States
919-962-3182 (Phone)
919-962-2068 (Fax)

Feedback to SSRN


Paper statistics
Abstract Views: 5,577
Downloads: 996
Download Rank: 11,657
References:  32
Citations:  28

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo1 in 0.390 seconds